The effects of trans-resveratrol on insulin resistance, inflammation, and microbiota in men with the metabolic syndrome: A pilot randomized, placebo-controlled clinical trial

BACKGROUND AND AIM: The metabolic syndrome (MetS) is a pathological condition comprised of abdominal obesity, insulin resistance, hypertension, and hyperlipidemia. It has become a major threat globally, resulting in rapidly increasing rates of diabetes, coronary heart disease, and stroke. The polyph...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Jeanne M., Eckardt, Patricia, Aleman, Jose O., da Rosa, Joel Correa, Liang, Yupu, Iizumi, Tadasu, Etheve, Stephane, Blaser, Martin J., L.Breslow, Jan, Holt, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Whioce Publishing Pte. Ltd. 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412609/
https://www.ncbi.nlm.nih.gov/pubmed/30873501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412609/
https://www.ncbi.nlm.nih.gov/pubmed/30873501

Ejemplares similares